abstract |
The invention relates to a pharmaceutical composition, containing a mixture of at least one cationic water-soluble (meth)acrylate copolymer, at least one water-insoluble polymer and at least one active agent with a solubility in demineralised water of 3,3 g/l or less, characterised in that the water-insoluble polymer and the active agent are present in a ratio of at most 3.5 to 1 parts by weight and the pharmaceutical composition has the following properties: the contained active agent is released in dissolved form in a medium buffered at pH 1.2, which, after 2 hours at pH 1.2, corresponds to at least 16 times the solubility value of the active agent alone at pH 1.2. |